Connecting you to content on EBSCOhost

Works by Vitfell-Rasmussen, Joanna

Results: 4

1

Real-life incidence of cardiotoxicity and associated risk factors in sarcoma patients receiving doxorubicin.

Published in:

Acta Oncologica, 2022, v. 61, n. 7, p. 801, doi. 10.1080/0284186X.2022.2082884

By:

Vitfell-Rasmussen, Joanna;
Krarup-Hansen, Anders;
Vaage-Nilsen, Merete;
Kümler, Thomas;
Zerahn, Bo

Publication type:

Article

2

A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas.

Published in:

Sarcoma, 2016, p. 1, doi. 10.1155/2016/2090271

By:

Vitfell-Rasmussen, Joanna;
Judson, Ian;
Safwat, Akmal;
Jones, Robin L.;
Rossen, Philip Blach;
Lind-Hansen, Maja;
Knoblauch, Poul;
Krarup-Hansen, Anders

Publication type:

Article

3

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.

Published in:

Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-1

By:

Rhoda Molife, L.;
Li Yan;
Vitfell-Rasmussen, Joanna;
Zernhelt, Adriane M.;
Sullivan, Daniel M.;
Cassier, Philippe A.;
Eric Chen;
Biondo, Andrea;
Tetteh, Ernestina;
Siu, Lillian L.;
Patnaik, Amita;
Papadopoulos, Kyriakos P.;
De Bono, Johann S.;
Tolcher, Anthony W.;
Minton, Susan

Publication type:

Article

4

Tumor reduction and symptom relief after electrochemotherapy in a patient with aggressive fibromatosis – a case report.

Published in:

2018

By:

Vitfell-Rasmussen, Joanna;
Sandvik, Rikke Mulvad;
Dahlstrøm, Karin;
Al-Farra, Gina;
Krarup-Hansen, Anders;
Gehl, Julie

Publication type:

Case Study